FDA finalizes guidance on patient-focused drug development
Regulatory NewsJoanne S. Eglovitch
Clinical outcome assessmentClinical TrialsPatient reported outcomesPatient-focused drug developmentPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyRegulatory strategyUnited StatesUS Food and Drug Administration (FDA)